Quest Diagnostics Incorporated (DGX) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Quest Diagnostics Incorporated (DGX) Bundle
Enhance your investment strategy with the (DGX) DCF Calculator! Utilize authentic Quest Diagnostics financial data, adjust growth predictions and expenses, and instantly observe how these modifications affect the intrinsic value of (DGX).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,726.0 | 9,437.0 | 10,788.0 | 9,883.0 | 9,252.0 | 9,753.7 | 10,282.5 | 10,840.0 | 11,427.8 | 12,047.4 |
| Revenue Growth, % | 0 | 22.15 | 14.32 | -8.39 | -6.38 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
| EBITDA | 1,585.0 | 2,411.0 | 3,159.0 | 1,820.0 | 1,732.0 | 2,194.2 | 2,313.2 | 2,438.6 | 2,570.8 | 2,710.2 |
| EBITDA, % | 20.52 | 25.55 | 29.28 | 18.42 | 18.72 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 |
| Depreciation | 329.0 | 361.0 | 408.0 | 437.0 | 439.0 | 410.3 | 432.5 | 456.0 | 480.7 | 506.8 |
| Depreciation, % | 4.26 | 3.83 | 3.78 | 4.42 | 4.74 | 4.21 | 4.21 | 4.21 | 4.21 | 4.21 |
| EBIT | 1,256.0 | 2,050.0 | 2,751.0 | 1,383.0 | 1,293.0 | 1,783.9 | 1,880.7 | 1,982.6 | 2,090.1 | 2,203.5 |
| EBIT, % | 16.26 | 21.72 | 25.5 | 13.99 | 13.98 | 18.29 | 18.29 | 18.29 | 18.29 | 18.29 |
| Total Cash | 1,192.0 | 1,158.0 | 872.0 | 315.0 | 686.0 | 904.8 | 953.9 | 1,005.6 | 1,060.1 | 1,117.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,063.0 | 1,520.0 | 1,438.0 | 1,195.0 | 1,210.0 | 1,333.6 | 1,405.9 | 1,482.2 | 1,562.5 | 1,647.2 |
| Account Receivables, % | 13.76 | 16.11 | 13.33 | 12.09 | 13.08 | 13.67 | 13.67 | 13.67 | 13.67 | 13.67 |
| Inventories | 123.0 | 223.0 | 208.0 | 192.0 | 190.0 | 192.7 | 203.2 | 214.2 | 225.8 | 238.0 |
| Inventories, % | 1.59 | 2.36 | 1.93 | 1.94 | 2.05 | 1.98 | 1.98 | 1.98 | 1.98 | 1.98 |
| Accounts Payable | 263.0 | 446.0 | 357.0 | 324.0 | 378.0 | 366.8 | 386.7 | 407.7 | 429.8 | 453.1 |
| Accounts Payable, % | 3.4 | 4.73 | 3.31 | 3.28 | 4.09 | 3.76 | 3.76 | 3.76 | 3.76 | 3.76 |
| Capital Expenditure | -400.0 | -418.0 | -403.0 | -404.0 | -408.0 | -426.0 | -449.1 | -473.5 | -499.2 | -526.2 |
| Capital Expenditure, % | -5.18 | -4.43 | -3.74 | -4.09 | -4.41 | -4.37 | -4.37 | -4.37 | -4.37 | -4.37 |
| Tax Rate, % | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 |
| EBITAT | 1,001.5 | 1,557.1 | 2,111.7 | 1,059.4 | 977.2 | 1,372.3 | 1,446.7 | 1,525.2 | 1,607.9 | 1,695.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 7.5 | 1,126.1 | 2,124.7 | 1,318.4 | 1,049.2 | 1,219.0 | 1,367.2 | 1,441.4 | 1,519.5 | 1,601.9 |
| WACC, % | 7.42 | 7.38 | 7.39 | 7.39 | 7.38 | 7.39 | 7.39 | 7.39 | 7.39 | 7.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,748.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1,634 | |||||||||
| Terminal Value | 30,310 | |||||||||
| Present Terminal Value | 21,220 | |||||||||
| Enterprise Value | 26,969 | |||||||||
| Net Debt | 4,812 | |||||||||
| Equity Value | 22,157 | |||||||||
| Diluted Shares Outstanding, MM | 113 | |||||||||
| Equity Value Per Share | 196.08 |
What You Will Get
- Real DGX Financial Data: Pre-filled with Quest Diagnostics' historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Quest Diagnostics' intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DGX Data: Pre-filled with Quest Diagnostics' historical performance and future projections.
- Fully Customizable Inputs: Modify revenue growth, profit margins, discount rates, tax implications, and capital expenditures.
- Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value reflecting your adjustments.
- Scenario Testing: Develop various forecasting scenarios to evaluate different valuation possibilities.
- User-Friendly Design: Intuitive, organized, and crafted for both professionals and newcomers.
How It Works
- Download: Access the ready-to-use Excel file with Quest Diagnostics Incorporated’s (DGX) financial data.
- Customize: Adjust forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations update in real-time.
- Test Scenarios: Create multiple projections and compare outcomes instantly.
- Make Decisions: Use the valuation results to guide your investment strategy.
Why Choose Quest Diagnostics Incorporated (DGX)?
- Save Time: Access comprehensive diagnostics solutions without the hassle of building from the ground up.
- Enhance Accuracy: Utilize dependable testing methods and data to minimize errors in results.
- Fully Customizable: Adjust services to meet your specific healthcare needs and preferences.
- Easy to Understand: User-friendly reports and visuals simplify the interpretation of diagnostic results.
- Trusted by Professionals: Renowned for delivering reliable services that healthcare providers rely on for patient care.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Quest Diagnostics Incorporated (DGX).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the healthcare sector.
- Consultants and Advisors: Offer clients precise valuation insights for Quest Diagnostics Incorporated (DGX) stock.
- Students and Educators: Utilize real-world data to practice and teach financial modeling in the healthcare industry.
- Health Sector Enthusiasts: Gain insights into how companies like Quest Diagnostics Incorporated (DGX) are valued in the market.
What the Template Contains
- Pre-Filled Data: Includes Quest Diagnostics' historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Quest Diagnostics' profitability, efficiency, and leverage.
- Customizable Inputs: Easily adjust revenue growth, margins, and tax rates.
- Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.